Literature DB >> 33378387

Study protocol for COvid-19 Vascular sERvice (COVER) study: The impact of the COVID-19 pandemic on the provision, practice and outcomes of vascular surgery.

Ruth A Benson1,2, Sandip Nandhra3.   

Abstract

BACKGROUND: The novel Coronavirus Disease 2019 (COVID-19) pandemic is having a profound impact on global healthcare. Shortages in staff, operating theatre space and intensive care beds has led to a significant reduction in the provision of surgical care. Even vascular surgery, often insulated from resource scarcity due to its status as an urgent specialty, has limited capacity due to the pandemic. Furthermore, many vascular surgical patients are elderly with multiple comorbidities putting them at increased risk of COVID-19 and its complications. There is an urgent need to investigate the impact on patients presenting to vascular surgeons during the COVID-19 pandemic. METHODS AND ANALYSIS: The COvid-19 Vascular sERvice (COVER) study has been designed to investigate the worldwide impact of the COVID-19 pandemic on vascular surgery, at both service provision and individual patient level. COVER is running as a collaborative study through the Vascular and Endovascular Research Network (VERN), an independent, international vascular research collaborative with the support of numerous national and international organisations). The study has 3 'Tiers': Tier 1 is a survey of vascular surgeons to capture longitudinal changes to the provision of vascular services within their hospital; Tier 2 captures data on vascular and endovascular procedures performed during the pandemic; and Tier 3 will capture any deviations to patient management strategies from pre-pandemic best practice. Data submission and collection will be electronic using online survey tools (Tier 1: SurveyMonkey® for service provision data) and encrypted data capture forms (Tiers 2 and 3: REDCap® for patient level data). Tier 1 data will undergo real-time serial analysis to determine longitudinal changes in practice, with country-specific analyses also performed. The analysis of Tier 2 and Tier 3 data will occur on completion of the study as per the pre-specified statistical analysis plan.

Entities:  

Year:  2020        PMID: 33378387     DOI: 10.1371/journal.pone.0243299

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  4 in total

1.  The effects of COVID-19 pandemic on patients with lower extremity peripheral arterial disease: A near miss disaster.

Authors:  Rafael Trunfio; Céline Deslarzes-Dubuis; Giacomo Buso; Marco Fresa; Juliette Brusa; Adrian Stefanescu; Matthieu Zellweger; Jean-Marc Corpataux; Sébastien Deglise; Lucia Mazzolai
Journal:  Ann Vasc Surg       Date:  2021-08-16       Impact factor: 1.466

2.  Impact of COVID-19 on the surgical profile of vascular surgery patients at a tertiary hospital in Curitiba, Brazil.

Authors:  Giovanna Golin Guarinello; Raissa Campos D'Amico; Ariadne Natalia Mileo Miranda; Jaqueline Novack; Francisco Eduardo Coral
Journal:  J Vasc Bras       Date:  2022-05-23

3.  Outcomes of Vascular and Endovascular Interventions Performed During the Coronavirus Disease 2019 (COVID-19) Pandemic.

Authors:  Ruth A Benson; Sandip Nandhra
Journal:  Ann Surg       Date:  2021-04-01       Impact factor: 13.787

4.  Treating Peripheral Arterial Occlusive Disease and Acute Limb Ischemia During a COVID-19 Pandemic in 2020.

Authors:  W Exelmans; L Knaapen; Ljm Boonman-de Winter; Pwhe Vriens; L van der Laan
Journal:  Ann Vasc Surg       Date:  2022-01-31       Impact factor: 1.607

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.